Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia GravisNeoplasms by Site, Paraneoplastic Syndromes, Nervous System, autoimmune disease, autoimmune disorder of the nervous system, immune system disorder, myasthenia gravis, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, neuromuscular junction disease, paraneoplastic syndromeRecruitingPhase 32026-07-30NCT07039916

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Immunovant Sciences GmbH8

88 results · Page 1 of 4

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Site Number - 1001New HavenUnited States1
Site Number - 1002Port CharlotteUnited States1
Site Number - 1003DallasUnited States1
Site Number - 1004San FranciscoUnited States1
Site Number - 1005East LansingUnited States1
Site Number - 1006ClearwaterUnited States1
Site Number - 1007TampaUnited States1
Site Number - 1009CharlottesvilleUnited States1
Site Number - 1010CarlsbadUnited States1
Site Number - 1011YukonUnited States1
Site Number - 1013DurhamUnited States1
Site Number - 1014AtlantaUnited States1
Site Number - 1015CharlestonUnited States1
Site Number - 1017PhoenixUnited States1
Site Number - 1018OmahaUnited States1
Site Number - 1019TotowaUnited States1
Site Number - 1020Chapel HillUnited States1
Site Number - 1021MemphisUnited States1
Site Number - 1022LexingtonUnited States1
Site Number - 1023Los AngelesUnited States1
Site Number - 1024Washington D.C.United States1
Site Number - 1025ScottsdaleUnited States1
Site Number - 1026DetroitUnited States1
Site Number - 1027Fort CollinsUnited States1
Site Number - 1028IrvineUnited States1